Established in 2011, SnackSafely.com provides straightforward, actionable information to help improve the lives of the estimated 32 million people in the US suffering with food allergies.

We strive to eliminate anaphylaxis by leveraging our on-line properties to educate, advocate, and connect the allergic community with products and services that help toward achieving this goal.

Our blog covers topics of interest to the food allergy community including news reports; ongoing research, clinical studies, trials and progress toward treatment and cure; general advocacy; and advice regarding food safety and school policies.

Please see our Terms of Service and Privacy Policy.

News Coverage

The Early Introduction Paradox: Why Infant ER Visits Are Rising Despite Successful Guidelines

Study Finds Advanced Parental Age Linked to Lower Allergy Risks

Nasus Pharma’s Nasal Epinephrine Powder Shows Faster Relief Than EpiPen

GSK’s $2.2 Billion Acquisition of Rapt Signals a New Era for Food Allergy Treatments

Beyond Desensitization: How PRT120 Rewires the Immune System for Peanut Allergy Remission

Teva's EpiPen Generic in Short Supply as US Launch Stalls

Sandoz Launches Symjepi Site with Usage Instructions

Bethenny Goes Incognito and Makes Us Laugh

ZEGO Takes Another Bold Step in Food Safety and Transparency

Food Allergy-Related Insurance Claims Up in Almost Every State in the...

Developer of Revolutionary "Powder" Epinephrine Auto-Injector Raises $12 Million

Symjepi List Price Undercuts Mylan and Teva EpiPen Generic Epinephrine Auto-Injectors

Sandoz Inc. launches SYMJEPI™ (epinephrine) in the US

Government Shutdown Delays Review of AR101 Peanut Oral Immunotherapy Candidate

Study: Intestinal Bacteria from Healthy Infants Prevent Food Allergy

Your School On Our Map

Put Your School on the Map